Regular users may be at risk for serous retinal detachment, retinal vascular occlusion, and ischemic optic neuropathy
Your search for esrd returned 64 results
Affordability of SGLT2i may contribute to the low prescription rate in CKD.
In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.
Hemoglobin levels lower, erythropoietin stimulating agent use higher, even for water lead levels below EPA threshold for regulatory action
A study found no significant increased risks for death or major adverse cardiac events among infected patients with established chronic kidney disease or end-stage kidney disease.
Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.
Risk for hip fracture increased with EPO doses of 50 to 149, 150 to 299, and 300 or greater vs <50 units/kg/week
In patients with IgA nephropathy, dapagliflozin significantly reduced the risk of CKD progression when added to ACEi/ARB therapy.
Although more research is needed, data suggest that the cardioprotective effect of direct oral anticoagulants may extend to patients with advanced CKD.
New study is the first to characterize pegloticase use in the dialysis population.